William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
-
Aclaris Therapeutics (ACRS) Announces Proposed Public Offering of Common Stock
-
Aclaris Announces Proposed Public Offering of Common Stock
-
Aclaris Therapeutics to Attend Upcoming Investor Conference
-
Aclaris Therapeutics to Attend Upcoming Investor Conferences
-
Aclaris Therapeutics (ACRS) Prices 3.26M Share Offering at $23.02/Sh
-
Aclaris Announces Pricing of Public Offering of Common Stock
-
Aclaris Therapeutics (ACRS) Plans $75M Common Stock Offering
-
Aclaris Announces Proposed Public Offering of Common Stock
-
Aclaris Therapeutics to Attend Upcoming Investor Conferences
-
Aclaris Therapeutics (ACRS) Prices 4M Stock Offering at $22.75/Share
-
Aclaris Announces Pricing of Public Offering of Common Stock
-
Aclaris Therapeutics (ACRS) to Offer up to $65M in Stock
-
Aclaris Announces Proposed Public Offering of Common Stock
-
Aclaris Therapeutics to Present at Upcoming Investor Conferences in June
-
Aclaris Therapeutics (ACRS) Enters $20M Common Stock Private Placement
-
Aclaris Therapeutics Announces $20.0 Million Private Placement
-
Aclaris Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
-
Aclaris Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
-
Aclaris Therapeutics (ACRS) IPO Opens 9% Higher
-
Aclaris Therapeutics (ACRS) IPO Prices at $11, Well Below Expected Range
-
Aclaris Announces Pricing of Initial Public Offering
-
Aclaris Announces Pricing of Initial Public Offering
-
Aclaris Therapeutics (ACRS) Files $86.25M Common Stock IPO

